© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to February
selective FXR partial agonist
orally efficacious in NASH models
from two 3M compound HTS and LBD
J. Med. Chem., Jan. 15, 2020
Novartis (GNF), San Diego, CA
LMB763 (nidufexor) (Novartis (GNF) oral in vivo selective FXR partial agonist)
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.